Tyloxapol inhibits RANKL-stimulated osteoclastogenesis and ovariectomized-induced bone loss by restraining NF-κB and MAPK activation

Objective: Tyloxapol is a non-ionic surfactant with diverse pharmacological effects including anti-inflammatory, anti-malignant tumor and antioxidant activities. However, the effect of tyloxapol on osteoclastogenesis has not been elucidated. In this study, we intended to clarify the effect of tyloxa...

Descripció completa

Dades bibliogràfiques

Autors principals:	Wen Guo, Haijun Li, Yan Lou, Yue Zhang, Jia Wang, Ming Qian, Haifeng Wei, Jianru Xiao, Youjia Xu
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2021-05-01
Col·lecció:	Journal of Orthopaedic Translation
Matèries:	Tyloxapol Osteoporosis Osteoclast Osteoblast Nuclear factor kappa-B (NF-κB) Mitogen-activated protein kinase (MAPK)
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S2214031X21000061
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!